On November 6, 2023, the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG), in connection with the November 2023 Health Care Compliance Association’s (HCCA) Healthcare Enforcement Compliance Conference, published the General Compliance Program Guidance (GCPG) as a revised reference guide for the healthcare compliance community and other healthcare stakeholders.
During the […]
MediSpend’s Advisory Services team recently presented a webinar on emerging transparency updates and requirements for pharmaceutical and medical device manufacturers. Notable updates included changes to the Centers for Medicare & Medicaid Services (CMS) Open Payments reporting, Connecticut’s new sales representative disclosure requirements and an update on the Italian Sunshine Act.
Numerous updates to […]
The Centers for Medicare and Medicaid Services (CMS) recently published their 2022 Open Payments data as well as newly submitted and updated payment records for previous program years.
The 2022 publication includes transactions that took place between January 1st and December 31st. Applicable manufacturers reported $12.59 billion in reportable payments, ownership and investment interests to healthcare […]
MediSpend’s Suj Patel and Frank Madden discuss ways to get and stay ahead of global transparency reporting obligations.
Life sciences organizations are subject to numerous legal and regulatory requirements, including an obligation to screen the healthcare professionals and organizations (HCP/Os) that they contract and engage with to ensure they are not caught off guard by any infractions that exist, a process known as sanctions screening. Sanctions screening involves verifying these individuals and entities […]
Recently, MediSpend’s Advisory Services team presented a webinar on emerging transparency updates and requirements for pharmaceutical and medical device manufacturers. Notable updates included changes to the Centers for Medicare & Medicaid Services (CMS) Open Payments reporting, Oregon’s new sales representative disclosure requirements, the Italian Sunshine Act and the Chilean Chamber of Pharmaceutical Innovation (CIF) disclosure […]
At MediSpend, we’re on a mission to empower life sciences companies to grow their business compliantly through our best-in-class software solutions and top-rated client services. To achieve this mission, we’ve assembled an incredible team and have laid a foundation of cultural attributes that help us make a difference in the life sciences industry.
Each year, MediSpend […]
January 18, 2022
Portsmouth, NH — MediSpend, a global technology company providing best-in-class solutions that empower life sciences companies to grow their business compliantly, reports another year of record-breaking growth with the addition of various new clients totaling nearly 150 life sciences companies leveraging the MediSpend Global Compliance Suite. With support from their new […]
Continued rapid growth leading to new innovations that further enable compliant HCP engagements.
Portsmouth, NH – July 27, 2021— MediSpend, a global technology company providing advanced, best-in-class compliance solutions for the life sciences industry, provides a glimpse into the future as rapid growth continues to fuel new product development and an expanded […]
SGE’s investment will support MediSpend’s ability to grow its best-in-class compliance solutions across the life sciences industry
Portsmouth, NH May 26, 2021 —MediSpend, a global technology company providing best-in-class solutions for the life sciences industry, today announced that it has received a majority investment from Susquehanna Growth Equity, LLC (SGE), an entrepreneur-centric growth equity […]
